New modalities in the systemic treatment of atopic dermatitis

dc.contributor.advisorGáspár, Krisztián
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Bőrgyógyászati Tanszék
dc.contributor.authorAli, Julia
dc.contributor.departmentDE--Általános Orvostudományi Kar
dc.contributor.opponentSzabó, Éva
dc.contributor.opponentMikaczo, Angéla
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Bőrgyógyászati Tanszék
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Tüdőgyógyászati Tanszék
dc.date.accessioned2023-08-16T08:47:43Z
dc.date.available2023-08-16T08:47:43Z
dc.date.created2023-02-20
dc.description.abstractAtopic dermatitis is a chronic inflammatory skin condition affecting many globally, marked by itching, redness, dryness, and eczematous lesions. Its development is intricate, involving genetics, environment, and immune factors. It's associated with conditions like asthma and allergic rhinitis. Traditionally, treatment involves managing symptoms with topical corticosteroids, systemic corticosteroids, and immunomodulatory agents like cyclosporine and azathioprine. These approaches can have drawbacks and are not universally effective. Recent advancements, however, have led to new therapies including biologics and JAK inhibitors. These target specific inflammatory pathways, showing efficacy in moderate-to-severe atopic dermatitis by reducing symptoms, lessening topical corticosteroid reliance, and enhancing quality of life.
dc.description.correctorLB
dc.description.courseáltalános orvos
dc.description.courselangangol
dc.description.degreeegységes, osztatlan
dc.format.extent36
dc.identifier.urihttps://hdl.handle.net/2437/358223
dc.language.isoen
dc.rights.accessHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectatopic
dc.subjectdermatitis
dc.subject.dspaceDEENK Témalista::Orvostudomány::Bőrgyógyászat
dc.titleNew modalities in the systemic treatment of atopic dermatitis
Fájlok